The Furoscix 80 mg/10 ml subcutaneous injection is intended for oedema in adult CKD patients, including those with nephrotic ...

The S&P 500 Index ($SPX) (SPY) on Friday closed up +2.13%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +1.65%, and the Nasdaq 100 Index ($IUXX) (QQQ ...

ALNY stock soars 62% in a year, driven by increasing Amvuttra and Givlaari sales. Its ongoing collaboration deals with RHHBY, NVS and REGN are progressing well.

Cardiorenal specialist scPharmaceuticals has won US Food and Drug Administration (FDA) approval for its supplemental New Drug Application (sNDA) for Furoscix (furosemide injection) to expand the ...

Axsome Therapeutics (AXSM) has received formal pre-New Drug Application meeting minutes from the U.S. Food and Drug Administration supporting a ...

This article is part of your SHN+ subscription In 2025, the baby boomer generation is standing at the industry’s doorstep.

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

The Californian company earlier announced the US Food and Drug Administration’s (FDA) acceptance of a supplemental New Drug Application (sNDA) for Zoryve (roflumilast) cream 0.05%, a once-daily, ...

This press release contains forward-looking statements about planned presentations at a scientific conference and a potential sNDA submission for Afrezza that involves risks and uncertainties.